In recent years, China’s online shopping titans have been muscling into the prescription drug market. When JD.com, Alibaba’s archrival, realized the health market spans well beyond retail, it spun out its healthcare unit into a subsidiary last May for a potential initial public offering. That startup, JD Health, gained a staggering valuation of $7 billion […]...